Triumvira Immunologics, Inc.

United States - Austin, Texas

• 17/03/2022
• Series A
• $100,000,000

At Triumvira Immunologics, Inc., our team is dedicated to a vision of finding a cure and providing new hope for patients with life-threatening disease.

Co-founded in 2015 by licensing technology out of McMaster University and Bloom Burton & Co., Triumvira is working to achieve this vision by developing a proprietary T cell Antigen Coupler (TAC) technology, thought to be safer and more efficacious than current cancer treatments including chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies.

We are an emergent US company with operations in the United States and Canada. We bring together talent from a wide range of disciplines including immunobiology, drug development, fundraising, commercialization and finance, with decades of experience across big pharma and small biotech, multiple industries and academia. We are passionate about science that pushes the limits, the patients that drive the heart of our work, and the wellness of our employees. We embrace flexibility. If you are looking for a career where you are encouraged to be innovative, challenge the status quo, and have some fun while doing it, Triumvira is the place for you.

For more information about Triumvira career opportunities, please see our Careers web page at:
https://triumvira.com/contact-us/careers/

Related People

Paul LammersFounder

United Kingdom - Austin, Texas,

Results-driven biopharmaceutical executive with extensive managerial experience in both public and private biopharmaceutical companies. Excited about the promise of Triumvira’s T cell Antigen Coupler (TAC) technology. Looking forward to bring multiple TAC targets into the clinic in years ahead!
Excited to have joined the Board of ImmunoMet, an oncology company operating out of JLABS in Houston.
Previously, as President & CEO of Mirna Therapeutics, able to raise approx. $165 million in private, non-dilutive, and public funding (took company public in 2015).
Served as Director on Boards of both for-profit and non-for-profit organizations. Driver of corporate goals, objectives and values, and P&L, budget and management team building responsibility in organizations of various sizes. Therapeutic experience in women’s and men’s health, neurodegenerative diseases, metabolic disorders, orphan drug diseases, and oncology.

LinkedIn https://www.linkedin.com/in/paul-lammers-7a27331b/